Moreover, the delivery of NPC2 via hepatotropic AAV8 has been shown to reduce inflammatory infiltration, decrease the expression of two early HCC indicators (survivin and glypican 3), and suppress the HCC onset occurring spontaneously in mice [103]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.